Tabrizi MA - Search Results

1

Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility.

Baraldi PG, Tabrizi MA, Gessi S, Borea PA. Baraldi PG, et al. Among authors: tabrizi ma. Chem Rev. 2008 Jan;108(1):238-63. doi: 10.1021/cr0682195. Chem Rev. 2008. PMID: 18181659 Review. No abstract available.

2

Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.

Baraldi PG, Fruttarolo F, Tabrizi MA, Preti D, Romagnoli R, El-Kashef H, Moorman A, Varani K, Gessi S, Merighi S, Borea PA. Baraldi PG, et al. Among authors: tabrizi ma. J Med Chem. 2003 Mar 27;46(7):1229-41. doi: 10.1021/jm021023m. J Med Chem. 2003. PMID: 12646033

3

Recent developments in the field of A2A and A3 adenosine receptor antagonists.

Baraldi PG, Tabrizi MA, Bovero A, Avitabile B, Preti D, Fruttarolo F, Romagnoli R, Varani K, Borea PA. Baraldi PG, et al. Among authors: tabrizi ma. Eur J Med Chem. 2003 Apr;38(4):367-82. doi: 10.1016/s0223-5234(03)00042-4. Eur J Med Chem. 2003. PMID: 12750024

4

New strategies for the synthesis of A3 adenosine receptor antagonists.

Baraldi PG, Bovero A, Fruttarolo F, Romagnoli R, Tabrizi MA, Preti D, Varani K, Borea PA, Moorman AR. Baraldi PG, et al. Among authors: tabrizi ma. Bioorg Med Chem. 2003 Sep 15;11(19):4161-9. doi: 10.1016/s0968-0896(03)00484-x. Bioorg Med Chem. 2003. PMID: 12951147

5

The A3 adenosine receptor: history and perspectives.

Borea PA, Varani K, Vincenzi F, Baraldi PG, Tabrizi MA, Merighi S, Gessi S. Borea PA, et al. Among authors: tabrizi ma. Pharmacol Rev. 2015;67(1):74-102. doi: 10.1124/pr.113.008540. Pharmacol Rev. 2015. PMID: 25387804 Review.

6

Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?

Baraldi PG, Cacciari B, Borean PA, Varanin K, Pastorin G, Da Ros T, Tabrizi MA, Fruttarolo F, Spalluto G. Baraldi PG, et al. Among authors: tabrizi ma. Curr Pharm Des. 2002;8(26):2299-332. doi: 10.2174/1381612023392838. Curr Pharm Des. 2002. PMID: 12369947 Review.

7

Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.

Baraldi PG, Romagnoli R, Pavani MG, Nuñez Mdel C, Tabrizi MA, Shryock JC, Leung E, Moorman AR, Uluoglu C, Iannotta V, Merighi S, Borea PA. Baraldi PG, et al. Among authors: tabrizi ma. J Med Chem. 2003 Feb 27;46(5):794-809. doi: 10.1021/jm0210212. J Med Chem. 2003. PMID: 12593659

8

Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemotherapic drugs: taxol and vindesine.

Merighi S, Mirandola P, Varani K, Gessi S, Capitani S, Leung E, Baraldi PG, Tabrizi MA, Borea PA. Merighi S, et al. Among authors: tabrizi ma. Biochem Pharmacol. 2003 Sep 1;66(5):739-48. doi: 10.1016/s0006-2952(03)00400-3. Biochem Pharmacol. 2003. PMID: 12948854

9

A glance at adenosine receptors: novel target for antitumor therapy.

Merighi S, Mirandola P, Varani K, Gessi S, Leung E, Baraldi PG, Tabrizi MA, Borea PA. Merighi S, et al. Among authors: tabrizi ma. Pharmacol Ther. 2003 Oct;100(1):31-48. doi: 10.1016/s0163-7258(03)00084-6. Pharmacol Ther. 2003. PMID: 14550503 Review.

10

Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.

Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA. Baraldi PG, et al. Among authors: tabrizi ma. J Med Chem. 2004 Mar 11;47(6):1434-47. doi: 10.1021/jm0309654. J Med Chem. 2004. PMID: 14998332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page